Louisiana Allows Medical Marijuana in Hospitals for Terminally Ill

Governor's Passive Approval Signals Policy Shift

Landry allowed the bill to become law by taking no action during the 10-day review window, a procedural route that avoids an outright veto but stops short of an endorsement. The Louisiana Constitution permits bills to take effect automatically if the governor neither signs nor vetoes within the statutory deadline. HB 391 becomes effective August 1, 2026.

The passive approval follows months of lobbying by hospice providers and patient advocates. They argued the hospital ban forced terminally ill patients to choose between pain relief and inpatient care.

Scope of the New Law

HB 391 applies exclusively to patients with terminal diagnoses who are receiving hospice or palliative care services in a licensed hospital or long-term care facility. It doesn't extend to general medical cannabis patients or to outpatient settings. Hospitals retain authority to establish internal policies governing where and how cannabis may be consumed on their premises.

The bill passed the Louisiana House 72-28 and the Senate 26-11 in May 2026, with bipartisan support concentrated among lawmakers representing rural districts with limited hospice infrastructure.

Federal Compliance and Liability Questions

Louisiana hospitals that accept Medicare or Medicaid funding remain subject to federal drug-free workplace requirements, creating a compliance gray zone the statute doesn't resolve. Legal counsel for the Louisiana Hospital Association noted in May testimony that facilities could face federal funding penalties if auditors interpret on-site cannabis use as a violation of the Drug-Free Workplace Act.

The Louisiana Department of Health hasn't issued guidance on how hospitals should document cannabis use in patient records. Nor has it clarified whether such documentation could trigger federal reporting obligations.

Timeline and Implementation

The law takes effect August 1, 2026. That gives hospitals eight weeks to draft internal policies and train staff. The Louisiana State Board of Medical Examiners confirmed in a June 2 advisory that physicians may continue to certify patients for medical cannabis under existing protocols; no additional certification is required for hospital use under HB 391.

Patient Eligibility Criteria

Only patients already enrolled in Louisiana's medical cannabis program and holding a valid registry identification card may use cannabis in hospitals under the new law. The statute doesn't create a fast-track enrollment process for newly diagnosed terminal patients. Enrollment currently requires a physician certification and a 7-10 business day processing window at the Louisiana Department of Health.

As of May 2026, Louisiana's medical cannabis program had 14,200 active patients, according to state registry data. The department doesn't publish breakdowns by qualifying condition.

Political Context

Landry's decision to let the bill become law without signature reflects the administration's reluctance to expand cannabis access while avoiding the political cost of vetoing a hospice-care measure. The governor hasn't issued a public statement on HB 391. His office declined to comment when contacted by the Louisiana Legislative Gazette on June 3.

Louisiana remains one of 12 states that prohibit smokable medical cannabis. HB 391 doesn't alter that restriction. Patients may use tinctures, capsules, and topicals only.

Next Steps for Providers

Hospitals must now decide whether to permit cannabis use and, if so, under what conditions. Early signals from the Louisiana Hospital Association suggest most facilities will adopt restrictive policies limiting use to private rooms and requiring advance notification. For full background on Louisiana's medical cannabis framework, see the CannIntel topic hub on Louisiana Medical Cannabis Program.

The first test case will likely emerge in August. That's when the law takes effect and a patient requests accommodation.